Medicortex Finland Oy is looking for investors to fund an analysis step of the recent clinical trial where children who have suffered TBI were recruited, and to accelerate R&D activities in order to develop a diagnostic test kit for mild traumatic brain injury.
Our pre-money valuation is about 10.7 M€ and the minimum investment is 3200 euro (500 shares). Share price is 6.40 €.
Yhtiön valuaatio on noin 10.7 milj.€. Minimisijoitus on 3200 euroa (500 osaketta). Osakkeen hinta on 6.40 €.